… Canine prostate is widely used as animal model in the preclinical evaluation of emerging
therapeutic interventions. Spontaneous benign prostatic hyperplasia (BPH) is common in adult …

… We decided to carry out preclinical in vivo study of … Prostate cancer (PC) is one of the most
common cancers in the world affecting men. PC in Europe is 2""/3“’ cause of cancer deaths, in …

… model array data with two recent human prostate cancer studies [14,15], we found that Sox4
and Tubb2a are especially relevant targets in human prostate cancer therapeutic studies. …

… The aim of the present study was to determine the effect of PG11047 in a non-small cell
lung cancer model alone and in combination with cisplatin, and in a prostate cancer model, …

… for initiating the essential preclinical tests of potential … models of prostate cancer to recapture
eventually all of the pathophysiological characteristics of the human disease. The models …

… Prostate cancer represents a histologically and clinically very heterogeneous disease. It can
… (1) Many identified prostate cancers are not life-threatening as they typically progress slowly…

… In this study, it was aimed to investigate 149 Tb-PSMA-617 for targeted α-therapy (TAT) using
a mouse model of prostate-specific membrane antigen (PSMA)-expressing prostate cancer…

Prostate-specific membrane antigen (PSMA) is expressed in normal human prostate epithelium
and is highly up-regulated in prostate cancer. We previously reported a series of novel …

… Prostate cancer (PCa) is one of the most common cancers in men in the United States and is
the second leading cause of male cancer death worldwide after lung cancer… animal models, …

… Our findings provided the first preclinical evidence supporting nicardipine as a novel
EED inhibitor that has the potential to be promptly tested in PCa patients to overcome …